Expanding CAR-T Therapies Beyond Cancer & Autoimmune Diseases into Mast Cell Diseases, Allergy & Immunology

• Exploring the underlying pathology of allergic diseases
• Designing CAR-T therapies to eliminate mast cells, the cellular cause of allergic reactions
• Defining the unmet need for mast cell targeting CAR-T cells

Speakers:

Sidharth Kerkar

Founder & Chief Executive Officer

AllerGene AI